Description: Innovations in insulin formulations aim to improve the accuracy and flexibility of diabetes treatment. Ultra-rapid-acting insulins mimic natural insulin secretion more closely, providing better postprandial glucose control. Long-acting insulin formulations are designed to produce more stable blood glucose profiles with fewer fluctuations and extended durations of action, reducing the need for frequent dosing. At the Diabetes and Endocrinology World Conference, leading researchers will present novel insulin technologies, facilitating groundbreaking discussions on enhancing diabetes care. New delivery methods, such as inhaled insulins and implants loaded with insulin, are also designed to provide non-invasive, patient-friendly alternatives. These will hopefully improve patient outcomes, simplify diabetes management, and reduce the risk of complications.